The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Acute myeloid leukemia: Epidemiology and etiology
Abstract
Acute myeloid leukemias (AMLs) are infrequent, yet highly malignant neoplasms responsible for a large number of cancer‐related deaths. The incidence has been near stable over the last years. It continuously shows 2 peaks in occurrence in early childhood and later adulthood. With an incidence of 3.7 per 100,000 persons and an age‐dependent mortality of 2.7 to nearly 18 per 100,000 persons, there is a rising awareness in the Western world of AML's special attributes resulting from an ever‐aging population. To objectively describe epidemiologic data on this patient population, recent publications were evaluated to make transparent the current trends and facts. A review of the literature is presented, reflecting highlights of current research with respect to AML etiology. To estimate outcome and discuss informed treatment decisions with AML patients of different age groups and different biologic risk categories, it is mandatory to consider that the outcome results reported in clinical trials were until now heavily biased toward younger patients, whereas the overall dismal prognosis documented in population‐based studies most likely reflects the exclusion of older patients from aggressive treatment. The etiology for most cases of AML is unclear, but a growing knowledge concerning leukemogenenic agents within chemotherapy regimens for other malignancies is already available. This includes specific associations of the most frequent balanced translocations in AML, including the “good‐risk” abnormalities comprised by the core binding factor leukemias (i.e., AML with the translocation (8;21) and inversion of chromosome 16, and acute promyelocytic leukemia with the translocation (15;17)). In contrast to these genetic alterations, epigenetic lesions, e.g., promoter silencing by hypermethylation of the p15/INK4b and other genes, are increasingly recognized as important in the pathogenesis of AML. Cancer 2006. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Known risk factors, such as genetic disorders, physical or chemical exposure, exposure to radiation or chemotherapy, exposure to viruses or antecedent haematologic disease account only for a small number of observed cases (Sandler & Collman, 1987;Deschler & Lubbert, 2006).”
From Anaemia and cigarette smoking (2008) · cites this paper as Deschler & Lubbert, 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Cheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Creutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
The roles of FLT3 in hematopoiesis and leukemia
Gilliland, D. G., & Griffin, J. D. (2002) · Blood · doi:10.1182/blood-2002-02-0492 · Cited by 1,558
Wingo, P. A., Tong, T., & Bolden, S. (1995) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.1.8 · Cited by 1,410
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Lowenberg, B., Downing, J. R., & Burnett, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411407 · Cited by 1,217
Leith, C. P., Kopecky, K. J., Godwin, J., McConnell, T., Slovak, M. L., Chen, I.-M., Head, D. R., Appelbaum, F. R., & Willman, C. L. (1997) · Blood · doi:10.1182/blood.v89.9.3323 · Cited by 859
Preston, D. L., Kusumi, S., Tomonaga, M., Izumi, S., Ron, E., Kuramoto, A., Kamada, N., Dohy, H., Matsui, T., Nonaka, H., et al. (1994) · Radiation Research · doi:10.2307/3578893 · Cited by 803
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
Pui, C.-H., Ribeiro, R. C., Hancock, M. L., Rivera, G. K., Evans, W. E., Raimondi, S. C., Head, D. R., Behm, F. G., Mahmoud, M. H., Sandlund, J. T., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252402 · Cited by 713
Bloomfield, C. D., Lawrence, D. D., Byrd, J. C., Carroll, A. J., Pettenati, M. J., Tantravahi, R. V., Patil, S., Davey, F. R., Berg, D. T., Schiffer, C. A., et al. (1998) · PubMed · Cited by 682
Le Beau, M. M., Albain, K. S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., Golomb, H. M., & Rowley, J. D. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.3.325 · Cited by 671
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B
Rai, K., Holland, J., Glidewell, O., Weinberg, V, Brunner, K., Obrecht, J., Preisler, H., Nawabi, I., Prager, D., Carey, R., et al. (1981) · Blood · doi:10.1182/blood.v58.6.1203.1203 · Cited by 532
Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
Pui, C.-H., Behm, F. G., Raimondi, S. C., Dodge, R. K., George, S. L., Rivera, G. K., Mirro, J., Kalwinsky, D. K., Dahl, G. V., Murphy, S. B., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210302 · Cited by 441
Löwenberg, B., van Putten, W., Theobald, M., Gmür, J., Verdonck, L., Sonneveld, P., Fey, M., Schouten, H., de Greef, G., Ferrant, A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025406 · Cited by 386
Long-term trends in cancer mortality in the United States, 1930-1998
Wingo, P. A., Cardinez, C. J., Landis, S. H., Greenlee, R. T., Ries, L. A. G., Anderson, R. N., & Thun, M. J. (2003) · Cancer · doi:10.1002/cncr.11380 · Cited by 385
Löwenberg, B., Zittoun, R., Kerkhofs, H., Jehn, U., Abels, J., Debusscher, L., Cauchie, C., Peetermans, M., Solbu, G., & Suciu, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1268 · Cited by 384
Cohen, S., Dadi, H., Shaoul, E., Sharfe, N., & Roifman, C. M. (1999) · Blood · doi:10.1182/blood.v93.6.2013.406k25_2013_2024 · Cited by 379
Pui, C.-H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322407 · Cited by 379
Pedersen-Bjergaard, J., Pedersen, M., Roulston, D., & Philip, P. (1995) · Blood · doi:10.1182/blood.v86.9.3542.bloodjournal8693542 · Cited by 306
Larson, R. A., Wang, Y., Banerjee, M., Wiemels, J., Hartford, C., Beau, M. M. L., & Smith, M. T. (1999) · Blood · doi:10.1182/blood.v94.2.803 · Cited by 304
Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia
Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H., & Nerlov, C. (2002) · Blood · doi:10.1182/blood.v99.6.1909 · Cited by 246
Management of Acute Myeloid Leukemia in Elderly Patients
Hiddemann, W., Kern, W., Schoch, C., Fonatsch, C., Heinecke, A., Wörmann, B., & Büchner, T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3569 · Cited by 243
Friend virus-induced erythroleukemia and the multistage nature of cancer
Ben-David, Y., & Bernsteint, A. (1991) · Cell · doi:10.1016/0092-8674(91)90428-2 · Cited by 237
Trends in leukemia incidence and survival in the United States (1973–1998)
Xie, Y., Davies, S. M., Xiang, Y., Robison, L. L., & Ross, J. A. (2003) · Cancer · doi:10.1002/cncr.11316 · Cited by 234
Late Effects of Treatment in Survivors of Childhood Acute Myeloid Leukemia
Leung, W., Hudson, M. M., Strickland, D. K., Phipps, S., Srivastava, D. K., Ribeiro, R. C., Rubnitz, J. E., Sandlund, J. T., Kun, L. E., Bowman, L. C., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3273 · Cited by 213
Sekeres, M. A., Stone, R. M., Zahrieh, D., Neuberg, D., Morrison, V, De Angelo, D. J., Galinsky, I., & Lee, S. J. (2004) · Leukemia · doi:10.1038/sj.leu.2403289 · Cited by 208
Pedersen-Bjergaard, J., Philip, P., Larsen, S. O., Andersson, M. V., Daugaard, G., Ersbøll, J., Sw, H., HOU-JENSEN, K., Nielsen, D. L., & Sigsgaard, T. (1993) · PubMed · Cited by 181
Epidemiology of acute leukemia in children and adults.
Sandler, D. P., & Ross, J. A. (1997) · PubMed · Cited by 179
Douer, D., Preston-Martin, S., Chang, E., Nichols, P., Watkins, K., & Levine, A. (1996) · Blood · doi:10.1182/blood.v87.1.308.308 · Cited by 179
Quesnel, B., Kantarjian, H., Bjergaard, J. P., Brault, P., Estey, E., Lai, J. L., Tilly, H., Stoppa, A. M., Archimbaud, E., & Harousseau, J. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.12.2370 · Cited by 177
Dillman, R., Davis, R., Green, M. R., Weiss, R. B., Gottlieb, A., Caplan, S. N., Kopel, S., Preisler, H., McIntyre, O. R., & Schiffer, C. A. (1991) · Blood · doi:10.1182/blood.v78.10.2520.2520 · Cited by 176
Christiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2003) · Leukemia · doi:10.1038/sj.leu.2403054 · Cited by 176
Smith, M. T., Wang, Y., Kane, E. V., Rollinson, S. J., Wiemels, J. L., Roman, E., Roddam, P. L., Cartwright, R. A., & Morgan, G. J. (2001) · Blood · doi:10.1182/blood.v97.5.1422 · Cited by 145
Deschler-Baier, B., de Witte, T., Mertelsmann, R. H., & Lübbert, M. (2006) · PubMed · Cited by 138
Self-citationGajewski, J., Ho, W. G., Nimer, S. D., Hirji, K. F., Gekelman, L., Jacobs, A. D., & Champlin, R. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1637 · Cited by 117
Mengis, C., Aebi, S. P., Tobler, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.186 · Cited by 111
How I treat older patients with AML
Estey, E. H. (2000) · Blood · doi:10.1182/blood.v96.5.1670.h8001670a_1670_1673 · Cited by 108
Birth Characteristics and Leukemia in Young Children
Reynolds, P., Behren, J. V., & Elkin, E. P. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.603 · Cited by 108
Andersen, M. K., Johansson, B., Larsen, S. O., & Pedersen-Bjergaard, J. (1998) · PubMed · Cited by 101
Revised classification of acute myeloid leukemia.
Head, D. R. (1996) · PubMed · Cited by 100
Estey, E. H., Thall, P. F., Kantarjian, H., Pierce, S. A., Kornblau, S. M., & Keating, M. J. (1997) · Leukemia · doi:10.1038/sj.leu.2400783 · Cited by 94
Cancer prevalence in the UK: results from the EUROPREVAL study
Forman, D., Stockton, D., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg169 · Cited by 93
Late effects in survivors of infant leukemia
Leung, W. H., Hudson, M. M., Zhu, Y., Rivera, G. K., Ribeiro, R., Sandlund, J. T., Bowman, L., We, E., Kun, L. E., & Pui, C.-H. (2000) · Leukemia · doi:10.1038/sj.leu.2401818 · Cited by 88
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia
Galm, O., Wilop, S., Lüders, C., Jost, E., Gehbauer, G., Herman, J. G., & Osieka, R. (2005) · Annals of Hematology · doi:10.1007/s00277-005-0005-0 · Cited by 82
Increase therapy-related leukemia secondary to breast cancer
Pm, C., Sgro, C., Parchin-Geneste, N., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401787 · Cited by 61
Population-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia
Sanderson, R., Johnson, P. R. E., Moorman, A. V., Roman, E., Willett, E. V., Taylor, P. R. A., Proctor, S. J., Bown, N. P., Ogston, S., & Bowen, D. (2006) · Leukemia · doi:10.1038/sj.leu.2404055 · Cited by 59
Epidemiology of Childhood Acute Myelogenous Leukemia
Bhatia, S., & Neglia, J. P. (1995) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199505000-00002 · Cited by 58
Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients
Rossi, G., Pelizzari, A. M., Bellotti, D., Tonelli, M., & Barlati, S. (2000) · Leukemia · doi:10.1038/sj.leu.2401711 · Cited by 54
The challenge of acute myeloid leukemia in older patients
Sekeres, M. A., & Stone, R. M. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00005 · Cited by 50
Epidemiology and clinical burden of acute myeloid leukemia
Redaelli, A. C. L., Lee, J. M., Stephens, J., & Pashos, C. L. (2003) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.3.5.695 · Cited by 48
Bowen, D., Frew, M. E., Rollinson, S. J., Roddam, P. L., Dring, A. M., Smith, M. T., Langabeer, S. E., & Morgan, G. J. (2003) · Blood · doi:10.1182/blood-2002-01-0228 · Cited by 45
Remission rate and survival in acute myeloid leukemia: Impact of selection and chemotherapy
Wåhlin, A., Hörnsten, P., & Jönsson, H. (1991) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1991.tb00547.x · Cited by 42
Kossman, S. E., & Weiss, M. A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<620::aid-cncr19>3.0.co;2-# · Cited by 42
p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies
Pötzsch, C., Voigtländer, T., & Lübbert, M. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0360-3 · Cited by 40
Self-citationPoor Survival of Treatment-Related Acute Nonlymphocytic Leukemia
Neugut, A. I., Robinson, E., Nieves, J., Murray, T., & Tsai, W. Y. (1990) · JAMA · doi:10.1001/jama.1990.03450080092038 · Cited by 40
Cancer mortality in the European Union, 1988–1997: The fall may approach 80,000 deaths a year
Levi, F., Lucchini, F., Negri, E., & Vecchia, C. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10235 · Cited by 33
The integration of molecular genetics into cancer management
Weinberg, R. A. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+<1701::aid-cncr2820701609>3.0.co;2-s · Cited by 31
Cytogenetic and environmental factors in the etiology of the acute leukemias in adults
SANDLER, D. P., & COLLMAN, G. W. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114741 · Cited by 31
The Impact of Biology on the Treatment of Secondary AML
Gojo, I., & Karp, J. E. (2001) · Cancer treatment and research · doi:10.1007/978-1-4615-1463-3_12 · Cited by 11
Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
(1996) · PubMed
Cited by
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Shallis, R. M., Wang, R., Davidoff, A., Ma, X., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.005 · Cited by 941
Prediction of acute myeloid leukaemia risk in healthy individuals
Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0317-6 · Cited by 850
Perspectives on the causes of childhood leukemia
Wiemels, J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.01.007 · Cited by 513
Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M. B., Wang, Y., Qian, Z., Jin, J., Zhang, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709313104 · Cited by 480
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
Metadata
- Authors
- Deschler, B., & Lübbert, M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-10-03
- Volume
- 107
- Issue
- 9
- Pages
- 2099-2107
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1996383959
- Cited by
- 646
- References
- 69
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.